Ref.TRGB20240822018.British SME developing oncological therapies for difficult-to-treat cancers seeks strategic research collaborations.
Cell membrane lipid phosphatidylserine (PS) is abnormally exposed on the surface of cancer cells, allowing tumor cells to evade the normal immune response. This SME is...